Free Trial
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel Free UPXI Stock Alerts

Upexi (UPXI) Financials

Upexi logo
$1.14 -0.01 (-0.87%)
Closing price 10/6/2026 04:00 PM Eastern
Extended Trading
$1.12 -0.02 (-1.75%)
As of 07:18 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Upexi

Annual Income Statements for Upexi

This table shows Upexi's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -4.29 -0.18 -8.01 -21 -24 -14 -246
Consolidated Net Income / (Loss)		 -5.38 2.98 -8.07 -21 -24 -14 -246
Net Income / (Loss) Continuing Operations		 -4.29 -0.13 -5.87 -14 -25 -14 -246
Total Pre-Tax Income 		-5.38 1.70 -6.39 -17 -26 -14 -246
Total Operating Income		 -4.84 1.43 -6.49 -12 -22 -12 -241
Total Gross Profit		 2.57 12 15 21 13 11 22
Total Revenue		 7.41 24 23 36 26 16 25
Operating Revenue		 7.41 24 23 36 26 16 25
Total Cost of Revenue		 4.84 12 8.20 15 13 4.94 2.63
Operating Cost of Revenue		 4.84 12 8.20 15 13 4.94 2.63
Total Operating Expenses		 7.41 10 21 30 35 23 263
Selling, General & Admin Expense		 6.04 8.08 9.14 6.88 6.77 12 26
Marketing Expense		 1.37 2.39 5.12 6.07 5.99 4.00 2.90
Depreciation Expense		 - - 0.57 0.91 1.27 0.68 0.38
Amortization Expense		 - - 0.98 2.57 2.41 0.08 0.08
Other Operating Expenses / (Income)		 - - 2.21 9.47 10 7.05 36
Impairment Charge		 - - 0.00 - 8.50 -0.27 2.17
Other Special Charges / (Income)		 - - 3.33 3.66 - -0.11 195
Total Other Income / (Expense), net		 0.55 -0.27 0.10 -8.46 -3.14 -1.18 -5.22
Interest Expense		 0.14 0.53 -0.10 4.72 3.12 1.17 3.27
Other Income / (Expense), net		 -0.41 0.80 -0.00 -3.74 -0.02 -0.01 -1.95
Income Tax Expense		 0.00 -1.28 0.52 3.05 -0.33 0.00 0.00
Basic Earnings per Share		 ($0.53) $0.25 ($0.43) ($18.94) ($23.03) ($1.73) ($3.87)
Weighted Average Basic Shares Outstanding		 10.10M 11.93M 16.22M 893.94K 1.03M 7.91M 63.54M
Diluted Earnings per Share		 ($0.53) $0.21 ($0.43) ($18.94) ($23.03) ($1.73) ($3.87)
Weighted Average Diluted Shares Outstanding		 10.10M 15.71M 16.22M 893.94K 1.03M 7.91M 63.54M
Weighted Average Basic & Diluted Shares Outstanding		 10.10M 14.26M - - - 58.89M 82.10M

Quarterly Income Statements for Upexi

This table shows Upexi's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -2.44 -7.02 -13 -1.63 -1.30 -3.83 -6.93 67 -179 -109 -25
Consolidated Net Income / (Loss)		 -3.83 -7.02 -11 -1.63 -1.30 -3.83 -6.93 67 -179 -109 -25
Net Income / (Loss) Continuing Operations		 -2.95 -4.28 -16 -1.63 -1.30 -3.83 -6.93 67 -179 -109 -25
Total Pre-Tax Income 		-3.64 -5.79 -14 -1.63 -1.30 -3.83 -6.93 67 -179 -109 -25
Total Operating Income		 -2.60 -5.04 -13 -1.34 -1.07 -3.59 -6.50 69 -175 -107 -28
Total Gross Profit		 4.57 1.27 1.56 2.93 2.97 1.56 3.40 8.28 6.71 4.35 3.02
Total Revenue		 7.42 5.22 5.43 4.36 4.01 3.16 4.29 9.24 8.05 4.56 3.15
Operating Revenue		 7.42 5.22 5.43 4.36 4.01 3.16 4.29 9.24 8.05 4.56 3.15
Total Cost of Revenue		 2.90 3.96 3.48 1.43 1.03 1.60 0.88 0.96 1.34 0.21 0.13
Operating Cost of Revenue		 2.90 3.96 3.48 1.43 1.03 1.60 0.88 0.96 1.34 0.21 0.13
Total Operating Expenses		 7.17 6.31 15 4.27 4.05 5.15 10 -61 182 111 31
Selling, General & Admin Expense		 1.58 1.79 1.82 1.37 1.55 2.64 6.38 9.26 5.52 4.93 6.69
Marketing Expense		 1.49 1.28 1.41 1.04 0.95 1.04 0.97 1.07 0.92 0.55 0.36
Depreciation Expense		 0.32 0.31 0.37 0.24 0.22 0.20 0.02 0.14 0.13 0.09 0.02
Amortization Expense		 0.66 0.66 0.43 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02
Other Operating Expenses / (Income)		 2.50 2.06 3.66 1.60 1.31 1.25 3.33 6.64 9.57 106 -86
Total Other Income / (Expense), net		 -1.04 -0.75 -0.88 -0.29 -0.23 -0.24 -0.41 -2.70 -3.56 -2.56 3.60
Interest Expense		 1.03 0.74 0.51 0.29 0.23 0.25 0.41 2.70 3.60 3.68 -6.71
Basic Earnings per Share		 ($2.00) ($4.03) ($12.51) - - ($2.87) ($0.88) - - ($1.67) ($0.39)
Weighted Average Basic Shares Outstanding		 1.02M 1.02M 1.03M 1.05M 1.05M 1.34M 7.91M 55.34M 60.83M 65.51M 63.54M
Diluted Earnings per Share		 ($2.00) ($4.03) ($12.51) - - ($2.87) ($0.88) - - ($1.67) ($0.39)
Weighted Average Diluted Shares Outstanding		 1.02M 1.02M 1.03M 1.05M 1.05M 1.34M 7.91M 88.48M 60.83M 65.51M 63.54M
Basic & Diluted Earnings per Share		 - - ($12.51) - - - ($0.88) - - - ($0.39)
Weighted Average Basic & Diluted Shares Outstanding		 20.89M 20.72M 0.00 1.04M 1.32M 37.25M 58.89M 59.92M 69.76M 70.26M 82.10M

Annual Cash Flow Statements for Upexi

This table details how cash moves in and out of Upexi's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Change in Cash & Equivalents		 -2.81 14 1.17 -2.66 -3.83 2.31 2.80
Net Cash From Operating Activities		 -4.16 2.94 -0.18 0.20 -0.10 -8.42 -21
Net Cash From Continuing Operating Activities		 -4.16 2.77 0.72 -7.42 -4.89 -8.42 -21
Net Income / (Loss) Continuing Operations		 -5.38 2.98 -2.10 -17 -24 -14 -246
Consolidated Net Income / (Loss)		 -5.38 2.98 -2.10 -17 -24 -14 -246
Depreciation Expense		 0.61 1.03 2.73 3.48 3.68 0.76 0.46
Amortization Expense		 0.00 0.34 0.00 1.03 1.23 0.03 3.66
Non-Cash Adjustments To Reconcile Net Income		 0.98 0.39 -1.20 9.18 12 2.56 217
Changes in Operating Assets and Liabilities, net		 -0.37 -1.80 2.36 -4.19 2.25 1.91 4.48
Net Cash From Investing Activities		 -1.46 -1.28 -11 -2.57 -3.38 -99 -31
Net Cash From Continuing Investing Activities		 -1.46 -1.28 -11 -0.02 0.83 -99 -31
Purchase of Property, Plant & Equipment		 -1.93 -1.42 -5.45 -0.94 -0.93 -0.39 -0.04
Acquisitions		 0.00 - 5.46 -1.05 -0.54 0.00 -0.75
Sale of Property, Plant & Equipment		 0.47 0.08 0.00 - 0.00 4.01 0.18
Other Investing Activities, net		 - - 0.00 1.96 2.30 -103 -30
Net Cash From Financing Activities		 2.82 12 3.70 -0.29 -0.35 110 54
Net Cash From Continuing Financing Activities		 2.82 12 3.70 6.03 -0.35 110 54
Repayment of Debt		 0.00 -0.76 -0.81 -3.46 -0.45 -3.53 -19
Repurchase of Common Equity		 - - 1.98 - - 0.00 -7.29
Issuance of Debt		 2.05 1.75 0.00 4.12 0.10 20 5.00
Issuance of Preferred Equity		 0.05 0.00 - - 0.00 0.33 0.00
Issuance of Common Equity		 0.72 11 - 6.13 0.00 93 75
Other Financing Activities, net		 - - - -0.75 0.00 0.25 0.11
Cash Interest Paid		 0.00 0.00 0.06 2.28 0.84 0.81 8.37
Cash Income Taxes Paid		 0.00 0.00 0.66 0.00 0.00 0.00 0.01

Quarterly Cash Flow Statements for Upexi

This table details how cash moves in and out of Upexi's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 -2.66 3.75 -3.66 1.13 -1.38 -0.18 2.74 -0.74 -0.62 1.87 2.30
Net Cash From Operating Activities		 0.19 0.78 2.72 -1.97 -1.38 -0.78 -4.29 -9.78 -2.68 -4.78 -3.72
Net Cash From Continuing Operating Activities		 0.34 -1.96 -1.19 -1.97 -1.38 -0.78 -4.29 -9.78 -2.68 -4.78 -3.72
Net Income / (Loss) Continuing Operations		 -5.15 -4.12 -16 -1.63 -1.30 2.93 -6.93 67 -179 112 -246
Depreciation Expense		 0.84 0.86 1.04 0.26 0.24 0.22 0.04 0.16 0.15 0.11 0.04
Amortization Expense		 0.40 0.20 0.25 0.00 - 0.37 -0.34 0.79 0.95 0.95 0.95
Non-Cash Adjustments To Reconcile Net Income		 -1.25 2.10 10 0.14 0.03 -5.58 1.21 -78 174 -119 240
Changes in Operating Assets and Liabilities, net		 0.92 0.87 2.92 -0.75 -0.36 1.29 1.73 0.84 0.95 1.12 1.57
Net Cash From Investing Activities		 -1.05 -0.18 -2.29 5.84 - -0.08 -105 -30 -6.49 7.88 -1.67
Net Cash From Continuing Investing Activities		 -0.98 -0.18 1.85 5.84 - -0.08 -105 -30 -6.49 7.88 -1.67
Other Investing Activities, net		 -0.79 - 2.16 2.00 - -0.05 - 0.00 -36 7.89 -1.67
Net Cash From Financing Activities		 0.91 -0.94 0.01 -2.73 - 0.68 112 39 8.55 -1.24 7.69
Net Cash From Continuing Financing Activities		 -2.38 -0.94 3.29 -2.73 - 0.68 112 39 8.55 -1.24 7.69
Repurchase of Common Equity		 - - - 0.00 - - - -2.99 2.19 -6.49 -0.01
Issuance of Common Equity		 - - - 0.00 - - - 50 10 7.47 7.69
Cash Interest Paid		 0.52 0.89 -0.67 0.08 0.21 0.03 0.48 1.95 0.56 3.33 2.54
Cash Income Taxes Paid		 - - - 0.00 - - - 0.00 - - 0.01

Annual Balance Sheets for Upexi

This table presents Upexi's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Total Assets		 6.40 27 48 64 24 124 180
Total Current Assets		 2.65 18 17 30 11 57 117
Cash & Equivalents		 0.89 15 7.15 4.49 0.66 2.98 5.78
Accounts Receivable		 0.17 1.28 0.94 1.13 0.61 0.16 0.10
Inventories, net		 1.45 2.09 4.73 4.80 1.43 1.15 0.27
Prepaid Expenses		 0.15 0.39 0.76 1.11 0.50 0.35 0.99
Other Current Assets		 - - 0.00 18 8.22 52 110
Plant, Property, & Equipment, net		 1.69 2.83 7.34 2.83 2.36 2.05 0.21
Total Noncurrent Assets		 2.07 6.13 24 31 9.73 65 63
Goodwill		 0.49 2.41 4.64 2.89 0.85 0.85 0.67
Intangible Assets		 1.24 1.85 8.76 6.92 0.24 0.16 0.09
Noncurrent Deferred & Refundable Income Taxes		 0.00 1.40 2.00 5.60 5.95 5.95 5.95
Other Noncurrent Operating Assets		 0.33 0.47 8.69 0.49 2.70 58 56
Total Liabilities & Shareholders' Equity		 6.40 27 48 64 24 124 180
Total Liabilities		 4.22 6.04 20 36 17 34 234
Total Current Liabilities		 3.52 5.82 10 22 13 33 71
Short-Term Debt		 1.68 0.45 3.87 1.59 0.00 21 57
Accounts Payable		 0.48 1.60 1.57 1.03 0.48 1.04 0.28
Accrued Expenses		 0.42 1.32 1.31 2.97 1.84 0.36 1.68
Current Deferred Revenue		 0.47 0.49 - 0.00 0.24 0.01 0.00
Current Employee Benefit Liabilities		 - - - - - 3.47 5.28
Other Current Liabilities		 0.46 1.96 3.37 16 9.63 6.33 4.25
Other Current Nonoperating Liabilities		 - - - 0.66 0.48 0.79 2.35
Total Noncurrent Liabilities		 0.70 0.22 9.58 14 4.34 1.15 163
Long-Term Debt		 0.37 0.00 8.88 5.97 2.11 0.00 162
Other Noncurrent Operating Liabilities		 0.34 0.22 0.70 7.61 2.23 1.15 0.36
Total Equity & Noncontrolling Interests		 0.45 21 29 28 6.52 90 -54
Total Preferred & Common Equity		 2.18 21 29 28 6.52 90 -54
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 0.45 21 29 28 6.52 90 -54
Common Stock		 7.32 25 35 52 53 151 253
Retained Earnings		 -7.10 -4.17 -6.27 -23 -47 -61 -307

Quarterly Balance Sheets for Upexi

This table presents Upexi's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets		 65 62 57 19 18 15 420 271 200
Total Current Assets		 25 23 17 6.79 6.11 3.97 220 171 122
Cash & Equivalents		 0.42 1.84 0.50 1.79 0.41 0.23 2.24 1.62 3.48
Accounts Receivable		 9.76 5.38 4.71 0.80 1.16 0.18 0.28 0.59 0.50
Inventories, net		 14 15 8.80 1.64 2.24 1.32 1.04 0.73 0.22
Prepaid Expenses		 0.96 0.70 0.72 0.39 0.31 0.23 1.48 1.30 0.99
Other Current Assets		 0.00 0.00 0.00 2.17 2.00 2.00 215 167 117
Plant, Property, & Equipment, net		 7.74 7.60 7.52 2.34 2.14 1.97 1.93 0.54 0.24
Total Noncurrent Assets		 33 32 32 9.47 9.28 9.13 197 99 78
Goodwill		 12 12 11 0.85 0.85 0.85 0.85 0.67 0.67
Intangible Assets		 12 11 9.47 0.22 0.20 0.23 188 0.87 0.86
Noncurrent Deferred & Refundable Income Taxes		 6.08 6.77 8.27 5.95 5.95 5.95 5.95 5.95 5.95
Other Noncurrent Operating Assets		 2.40 2.10 3.56 2.46 2.28 2.10 1.77 92 71
Total Liabilities & Shareholders' Equity		 65 62 57 19 18 15 420 271 200
Total Liabilities		 38 37 34 14 14 13 209 222 252
Total Current Liabilities		 20 24 24 9.77 11 11 65 78 71
Short-Term Debt		 4.26 4.21 5.47 6.76 1.06 0.95 51 64 57
Accounts Payable		 4.64 3.02 2.12 0.58 1.00 1.41 2.18 0.67 0.29
Accrued Expenses		 4.40 3.15 3.39 1.27 1.06 1.32 4.12 5.08 2.17
Current Deferred Revenue		 0.15 0.10 0.11 0.18 0.14 0.02 0.05 0.05 0.00
Current Employee Benefit Liabilities		 - - - - - - - - 4.51
Other Current Liabilities		 6.59 14 13 0.54 6.73 6.26 6.16 5.64 4.30
Other Current Nonoperating Liabilities		 - - 0.00 0.45 0.63 0.83 1.55 2.90 2.27
Total Noncurrent Liabilities		 18 12 10 3.80 3.15 2.42 144 145 181
Long-Term Debt		 2.15 6.62 4.79 1.96 1.31 0.58 143 144 181
Other Noncurrent Operating Liabilities		 15 5.82 5.46 1.84 1.84 1.84 1.15 0.46 0.44
Total Equity & Noncontrolling Interests		 28 25 22 5.03 3.76 1.85 211 49 -52
Total Preferred & Common Equity		 28 25 22 5.03 3.76 1.85 211 49 -52
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 28 25 22 5.03 3.76 1.85 211 49 -52
Common Stock		 52 52 53 54 54 55 205 222 230
Retained Earnings		 -25 -27 -31 -48 -50 -54 6.20 -173 -282

Annual Metrics And Ratios for Upexi

This table displays calculated financial ratios and metrics derived from Upexi's official financial filings.

Metric 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
DEI Shares Outstanding		 0.00 0.00 16,783,631.00 36,189,496.00 20,889,384.00 37,253,373.00 70,261,828.00
DEI Adjusted Shares Outstanding		 0.00 0.00 839,182.00 1,809,475.00 1,044,469.00 37,253,373.00 70,261,828.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 0.00 -9.55 -11.50 -22.65 -0.37 -3.50
Growth Metrics		 - - - - - - -
Revenue Growth		 0.00% 225.04% -4.27% 57.99% -27.42% -40.22% 58.10%
EBITDA Growth		 0.00% 177.66% -204.43% -206.25% -52.64% 33.35% -1,936.12%
EBIT Growth		 0.00% 142.44% -391.59% -146.83% -40.27% 44.39% -1,840.71%
NOPAT Growth		 0.00% 173.99% -281.27% -89.25% -82.91% 44.35% -1,826.81%
Net Income Growth		 0.00% 155.32% -370.79% -165.00% -10.68% 42.16% -1,698.17%
EPS Growth		 0.00% 139.62% -304.76% -165.00% -10.68% 92.49% -123.70%
Operating Cash Flow Growth		 0.00% 170.58% -106.15% 212.08% -150.02% -8,208.71% -148.80%
Free Cash Flow Firm Growth		 0.00% 0.00% -2,140.69% 122.07% -221.94% -1,304.45% -104.63%
Invested Capital Growth		 0.00% 113.45% 339.84% -47.66% -48.60% 1,185.56% 49.80%
Revenue Q/Q Growth		 0.00% 0.00% -14.14% -47.66% 1,211.20% -4.18% -4.36%
EBITDA Q/Q Growth		 0.00% 0.00% -59.15% -350.22% -28.19% 41.73% -10.15%
EBIT Q/Q Growth		 0.00% 0.00% -83.51% -106.86% -18.72% 44.38% -10.61%
NOPAT Q/Q Growth		 0.00% 0.00% 59.39% -58.52% -48.12% 35.45% -9.72%
Net Income Q/Q Growth		 0.00% 0.00% -435.02% -91.60% 22.79% 31.44% -7.71%
EPS Q/Q Growth		 0.00% 0.00% -437.50% 0.00% 22.79% 89.40% -10.89%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% -103.61% 279.10% 97.91% -494.16% 2.64%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 114.23% -133.19% -992.84% 33.52%
Invested Capital Q/Q Growth		 0.00% 0.00% 28.31% -74.22% -71.60% 2,628.55% -12.26%
Profitability Metrics		 - - - - - - -
Gross Margin		 34.67% 49.38% 64.47% 57.68% 48.49% 68.74% 89.48%
EBITDA Margin		 -62.53% 14.94% -16.30% -31.59% -66.43% -74.07% -954.80%
Operating Margin		 -65.27% 5.92% -28.13% -33.70% -84.93% -79.06% -963.46%
EBIT Margin		 -70.78% 9.24% -28.15% -43.98% -84.99% -79.06% -971.24%
Profit (Net Income) Margin		 -72.64% 12.36% -34.97% -58.66% -89.45% -86.55% -984.34%
Tax Burden Percent		 100.00% 175.63% 126.28% 126.06% 92.40% 100.00% 100.00%
Interest Burden Percent		 102.64% 76.18% 98.39% 105.81% 113.90% 109.48% 101.35%
Effective Tax Rate		 0.00% -75.63% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -101.38% 47.86% -23.60% -35.98% -126.53% -14.97% -124.44%
ROIC Less NNEP Spread (ROIC-NNEP)		 -170.52% 39.41% 37.35% 251.27% 40.54% -63.58% -190.46%
Return on Net Nonoperating Assets (RNNOA)		 -1,092.18% -20.36% -8.63% -39.45% -11.21% -13.36% -1,231.91%
Return on Equity (ROE)		 -1,193.56% 27.49% -32.23% -75.43% -137.74% -28.33% -1,356.34%
Cash Return on Invested Capital (CROIC)		 0.00% -24.53% -149.50% 26.59% -62.33% -186.10% -164.31%
Operating Return on Assets (OROA)		 -81.95% 13.23% -17.14% -28.54% -51.49% -16.97% -159.77%
Return on Assets (ROA)		 -84.11% 17.70% -21.30% -38.07% -54.19% -18.58% -161.92%
Return on Common Equity (ROCE)		 -1,193.56% 27.49% -32.16% -75.96% -139.76% -28.33% -1,356.34%
Return on Equity Simple (ROE_SIMPLE)		 -247.08% 14.04% -28.02% -75.42% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -3.39 2.51 -4.54 -8.60 -16 -8.75 -169
NOPAT Margin		 -45.69% 10.40% -19.69% -23.59% -59.45% -55.34% -674.42%
Net Nonoperating Expense Percent (NNEP)		 69.14% 8.45% -60.95% -287.25% -167.07% 48.62% 66.02%
Return On Investment Capital (ROIC_SIMPLE)		 - - - -24.29% -182.34% -7.91% -101.61%
Cost of Revenue to Revenue		 65.33% 50.62% 35.53% 42.32% 49.82% 31.26% 10.52%
SG&A Expenses to Revenue		 81.44% 33.55% 39.63% 18.87% 25.60% 75.49% 105.60%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 99.94% 43.46% 92.58% 81.10% 133.41% 148.46% 1,052.94%
Earnings before Interest and Taxes (EBIT)		 -5.25 2.23 -6.49 -16 -22 -12 -243
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -4.64 3.60 -3.76 -12 -18 -12 -239
Valuation Ratios		 - - - - - - -
Price to Book Value (P/BV)		 24.38 0.64 2.45 1.44 1.16 1.23 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.80 4.60 2.20 1.39 3.36 0.00
Price to Revenue (P/Rev)		 1.48 0.57 3.06 1.12 0.29 7.02 2.20
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 3.64 0.00 2.43 2.63 1.07 1.19 1.66
Enterprise Value to Revenue (EV/Rev)		 1.64 0.00 3.30 1.19 0.34 8.13 10.76
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 213.08 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 6.80 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - -
Debt to Equity		 4.54 0.02 0.44 0.27 0.32 0.23 -4.08
Long-Term Debt to Equity		 0.81 0.00 0.31 0.21 0.32 0.00 -3.02
Financial Leverage		 6.40 -0.52 -0.23 -0.16 -0.28 0.21 6.47
Leverage Ratio		 14.19 1.55 1.51 1.98 2.54 1.52 8.38
Compound Leverage Factor		 14.56 1.18 1.49 2.10 2.90 1.67 8.49
Debt to Total Capital		 81.95% 2.06% 30.66% 21.36% 24.44% 18.58% 132.43%
Short-Term Debt to Total Capital		 67.34% 2.06% 9.32% 4.50% 0.00% 18.58% 34.53%
Long-Term Debt to Total Capital		 14.61% 0.00% 21.34% 16.86% 24.44% 0.00% 97.90%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.13% -1.43% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 18.05% 97.93% 69.08% 80.07% 75.56% 81.42% -32.43%
Debt to EBITDA		 -0.44 0.12 -3.39 -0.66 -0.12 -1.76 -0.92
Net Debt to EBITDA		 -0.25 -3.91 -1.49 -0.26 -0.08 -1.50 -0.90
Long-Term Debt to EBITDA		 -0.08 0.00 -2.36 -0.52 -0.12 0.00 -0.68
Debt to NOPAT		 -0.61 0.18 -2.81 -0.88 -0.13 -2.35 -1.30
Net Debt to NOPAT		 -0.34 -5.62 -1.23 -0.35 -0.09 -2.01 -1.27
Long-Term Debt to NOPAT		 -0.11 0.00 -1.95 -0.69 -0.13 0.00 -0.96
Altman Z-Score		 -1.70 2.84 2.17 0.06 -4.62 1.32 -6.25
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.22% -0.70% -1.47% 0.00% 0.00%
Liquidity Ratios		 - - - - - - -
Current Ratio		 0.75 3.14 1.68 1.34 0.90 1.74 1.64
Quick Ratio		 0.30 2.72 0.80 0.25 0.10 0.10 0.08
Cash Flow Metrics		 - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -1.28 -29 6.35 -7.75 -109 -223
Operating Cash Flow to CapEx		 -284.69% 218.84% -3.32% 21.62% -10.87% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 -2.42 0.00 1.35 -2.48 -92.69 -68.02
Operating Cash Flow to Interest Expense		 -30.09 5.54 0.00 0.04 -0.03 -7.18 -6.40
Operating Cash Flow Less CapEx to Interest Expense		 -40.66 3.01 0.00 -0.16 -0.33 -4.09 -6.36
Efficiency Ratios		 - - - - - - -
Asset Turnover		 1.16 1.43 0.61 0.65 0.61 0.21 0.16
Accounts Receivable Turnover		 44.89 33.40 20.80 35.29 30.54 41.37 196.25
Inventory Turnover		 3.34 6.88 2.40 3.24 4.23 3.83 3.71
Fixed Asset Turnover		 4.39 10.66 4.54 7.17 10.20 7.17 22.12
Accounts Payable Turnover		 10.00 11.68 5.16 11.86 17.45 6.50 3.99
Days Sales Outstanding (DSO)		 8.13 10.93 17.55 10.34 11.95 8.82 1.86
Days Inventory Outstanding (DIO)		 109.17 53.02 151.88 112.78 86.37 95.41 98.44
Days Payable Outstanding (DPO)		 36.50 31.26 70.74 30.78 20.92 56.15 91.38
Cash Conversion Cycle (CCC)		 80.80 32.69 98.68 92.34 77.41 48.08 8.92
Capital & Investment Metrics		 - - - - - - -
Invested Capital		 3.34 7.13 31 16 8.44 108 162
Invested Capital Turnover		 2.22 4.60 1.20 1.53 2.13 0.27 0.18
Increase / (Decrease) in Invested Capital		 0.00 3.79 24 -15 -7.98 100 54
Enterprise Value (EV)		 12 -0.47 76 43 8.99 129 269
Market Capitalization		 11 14 70 41 7.54 111 55
Book Value per Share		 $0.04 $1.78 $1.71 $1.57 $0.31 $2.42 ($0.77)
Tangible Book Value per Share		 ($0.13) $1.42 $0.91 $1.02 $0.26 $0.89 ($0.78)
Total Capital		 2.50 22 42 35 8.62 111 166
Total Debt		 2.05 0.45 13 7.56 2.11 21 220
Total Long-Term Debt		 0.37 0.00 8.88 5.97 2.11 0.00 162
Net Debt		 1.16 -14 5.60 2.98 1.45 18 214
Capital Expenditures (CapEx)		 1.46 1.34 5.45 0.94 0.93 -3.62 -0.13
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.07 -1.61 3.66 4.63 -1.90 42 97
Debt-free Net Working Capital (DFNWC)		 0.81 13 11 9.21 -1.24 45 103
Net Working Capital (NWC)		 -0.87 12 6.93 7.62 -1.24 24 46
Net Nonoperating Expense (NNE)		 2.00 -0.47 3.52 13 7.93 4.93 77
Net Nonoperating Obligations (NNO)		 2.89 -14 2.52 -11 1.92 18 216
Total Depreciation and Amortization (D&A)		 0.61 1.37 2.73 4.51 4.91 0.79 4.11
Debt-free, Cash-free Net Working Capital to Revenue		 -0.99% -6.70% 15.86% 12.71% -7.17% 264.36% 388.64%
Debt-free Net Working Capital to Revenue		 10.98% 53.63% 46.86% 25.28% -4.67% 283.18% 411.76%
Net Working Capital to Revenue		 -11.73% 51.77% 30.06% 20.91% -4.67% 153.14% 182.56%
Earnings Adjustments		 - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.25 $0.00 ($19.20) ($23.03) ($1.73) ($3.87)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 11.93M 0.00 893.90K 1.03M 7.91M 63.54M
Adjusted Diluted Earnings per Share		 $0.00 $0.21 $0.00 ($19.20) ($23.03) ($1.73) ($3.87)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 15.71M 0.00 893.90K 1.03M 7.91M 63.54M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 14.26M 0.00 0.00 0.00 58.89M 82.10M
Normalized Net Operating Profit after Tax (NOPAT)		 -3.39 1.00 -2.21 -6.03 -9.78 -8.94 -31
Normalized NOPAT Margin		 -45.69% 4.14% -9.60% -16.55% -36.96% -56.53% -122.13%
Pre Tax Income Margin		 -72.64% 7.04% -27.70% -46.53% -96.80% -86.55% -984.34%
Debt Service Ratios		 - - - - - - -
EBIT to Interest Expense		 -37.91 4.20 0.00 -3.40 -7.19 -10.65 -74.18
NOPAT to Interest Expense		 -24.47 4.72 0.00 -1.82 -5.03 -7.45 -51.51
EBIT Less CapEx to Interest Expense		 -48.48 1.67 0.00 -3.60 -7.49 -7.57 -74.14
NOPAT Less CapEx to Interest Expense		 -35.04 2.19 0.00 -2.02 -5.33 -4.37 -51.47
Payout Ratios		 - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 24.49% 0.00% 0.00% 0.00% -2.96%

Quarterly Metrics And Ratios for Upexi

This table displays calculated financial ratios and metrics derived from Upexi's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 20,306,870.00 20,889,384.00 20,889,384.00 20,889,384.00 1,040,924.00 1,320,924.00 37,253,373.00 58,888,756.00 - 69,760,581.00 70,261,828.00
DEI Adjusted Shares Outstanding		 1,015,344.00 1,044,469.00 1,044,469.00 1,044,469.00 1,040,924.00 1,320,924.00 37,253,373.00 58,888,756.00 - 69,760,581.00 70,261,828.00
DEI Earnings Per Adjusted Shares Outstanding		 -2.40 -6.72 -12.30 -1.56 -1.25 -2.90 -0.19 1.13 - -1.57 -0.35
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -72.24% -76.13% 123.19% -47.98% -46.04% -39.49% -20.98% 112.09% 101.03% 44.19% -26.57%
EBITDA Growth		 -281.36% -283.08% -47.13% -655.83% 39.34% 24.80% 43.61% 6,630.52% -20,802.71% -3,384.89% -294.81%
EBIT Growth		 -53.22% -136.70% -36.14% 8.90% 58.89% 28.96% 51.29% 5,279.53% -16,236.23% -2,846.01% -328.19%
NOPAT Growth		 -52.95% -136.22% -120.22% 8.29% 58.74% 28.80% 51.34% 7,499.33% -16,240.38% -2,876.84% -328.19%
Net Income Growth		 -179.33% -153.88% 38.85% 10.62% 66.01% 45.41% 37.00% 4,206.12% -13,649.60% -2,753.69% -254.39%
EPS Growth		 -179.33% 0.00% 38.85% 0.00% 0.00% 28.78% 92.97% 0.00% 0.00% 41.81% 55.68%
Operating Cash Flow Growth		 -96.93% 157.68% 233.87% 47.93% -837.88% -199.38% -257.58% -395.30% -93.76% -513.40% 13.25%
Free Cash Flow Firm Growth		 162.51% 174.73% -112.89% 1,074.94% 21.49% -23.66% -7,482.01% -1,690.46% -1,467.77% -1,202.01% 29.71%
Invested Capital Growth		 -41.40% -53.33% -48.60% -63.02% -81.58% -86.62% 1,185.56% 3,148.25% 3,959.71% 4,558.34% 49.80%
Revenue Q/Q Growth		 -11.37% -29.64% 3.91% -19.74% -8.06% -21.10% 35.70% 115.44% -12.85% -43.40% -30.90%
EBITDA Q/Q Growth		 -867.38% -190.51% -202.25% 91.10% 22.36% -260.13% -126.65% 1,130.49% -348.50% 39.96% 74.32%
EBIT Q/Q Growth		 -78.14% -93.37% -164.51% 90.00% 19.62% -234.19% -81.37% 1,163.14% -353.52% 39.73% 73.64%
NOPAT Q/Q Growth		 -78.66% -93.71% -165.33% 90.01% 19.62% -234.26% -81.31% 1,618.93% -277.51% 39.11% 73.92%
Net Income Q/Q Growth		 -110.50% -83.32% -56.62% 85.21% 19.95% -194.45% -80.75% 1,063.78% -368.06% 38.89% 77.55%
EPS Q/Q Growth		 -110.50% -83.32% -56.62% 0.00% 0.00% 0.00% 69.34% 0.00% 0.00% 0.00% 76.65%
Operating Cash Flow Q/Q Growth		 104.95% 317.73% 247.11% -172.60% 29.91% 43.74% -450.36% -128.21% 72.58% -78.12% 22.17%
Free Cash Flow Firm Q/Q Growth		 1,185.66% 35.16% -104.53% 1,565.42% 35.28% -15.07% -550.29% -207.40% -16.34% 31.57% 71.28%
Invested Capital Q/Q Growth		 2.64% -13.73% -71.60% 47.06% -48.86% -37.36% 2,628.55% 271.58% -36.08% -28.12% -12.26%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 61.52% 24.27% 28.75% 67.26% 74.25% 49.33% 79.39% 89.65% 83.35% 95.47% 95.99%
EBITDA Margin		 -18.51% -76.42% -222.27% -24.64% -20.81% -94.97% -158.62% 758.73% -2,163.59% -2,295.31% -852.82%
Operating Margin		 -35.04% -96.46% -246.28% -30.65% -26.79% -113.50% -151.65% 748.45% -2,177.89% -2,343.29% -884.38%
EBIT Margin		 -35.17% -96.66% -246.03% -30.65% -26.79% -113.48% -151.67% 748.45% -2,177.34% -2,318.59% -884.38%
Profit (Net Income) Margin		 -51.58% -134.37% -202.53% -37.31% -32.49% -121.24% -161.48% 722.40% -2,222.11% -2,399.42% -779.39%
Tax Burden Percent		 105.09% 121.32% 79.28% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 139.54% 114.59% 103.84% 121.75% 121.26% 106.83% 106.47% 96.52% 102.06% 103.49% 88.13%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -7.51% 0.00% -366.94% -20.94% -17.48% -79.95% -28.71% 74.56% -285.76% -453.28% -114.22%
ROIC Less NNEP Spread (ROIC-NNEP)		 -20.46% 0.00% -332.50% -31.28% -27.00% -106.95% -52.09% 72.15% -338.88% -482.20% -118.53%
Return on Net Nonoperating Assets (RNNOA)		 -10.20% 0.00% 91.94% -12.82% -10.68% -43.76% -10.94% 66.74% -1,365.75% 2,304.12% -766.63%
Return on Equity (ROE)		 -17.72% -104.24% -275.00% -33.76% -28.17% -123.71% -39.66% 141.30% -1,651.51% 1,850.83% -880.85%
Cash Return on Invested Capital (CROIC)		 33.79% 49.98% -62.33% 23.97% 66.33% 72.33% -186.10% -160.14% -252.06% -354.04% -164.31%
Operating Return on Assets (OROA)		 -7.24% 0.00% -149.06% -16.40% -12.79% -53.75% -32.56% 70.67% -373.22% -562.59% -145.48%
Return on Assets (ROA)		 -10.61% 0.00% -122.70% -19.96% -15.50% -57.42% -34.66% 68.21% -380.90% -582.20% -128.21%
Return on Common Equity (ROCE)		 -17.77% -104.78% -279.04% -33.76% -28.17% -123.71% -39.66% 141.30% -1,651.51% 1,850.84% -880.85%
Return on Equity Simple (ROE_SIMPLE)		 -103.63% -138.92% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -1.82 -3.53 -9.36 -0.93 -0.75 -2.51 -4.55 69 -123 -75 -19
NOPAT Margin		 -24.53% -67.52% -172.40% -21.45% -18.76% -79.45% -106.16% 748.45% -1,524.53% -1,640.31% -619.06%
Net Nonoperating Expense Percent (NNEP)		 12.95% 20.19% -34.43% 10.34% 9.51% 27.00% 23.38% 2.41% 53.11% 28.92% 4.30%
Return On Investment Capital (ROIC_SIMPLE)		 -5.02% -10.91% -108.51% -6.80% -12.27% -74.47% -4.11% 17.10% -47.89% -40.10% -11.75%
Cost of Revenue to Revenue		 39.01% 75.73% 64.11% 32.74% 25.75% 50.67% 20.61% 10.35% 16.65% 4.53% 4.01%
SG&A Expenses to Revenue		 21.34% 34.28% 33.51% 31.39% 38.66% 83.62% 148.68% 100.19% 68.59% 108.22% 212.35%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 96.56% 120.73% 275.03% 97.90% 101.04% 162.83% 233.50% -658.81% 2,261.24% 2,438.77% 980.37%
Earnings before Interest and Taxes (EBIT)		 -2.61 -5.05 -13 -1.34 -1.07 -3.59 -6.50 69 -175 -106 -28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -1.37 -3.99 -12 -1.07 -0.83 -3.00 -6.80 70 -174 -105 -27
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.93 0.55 1.16 0.81 0.97 1.49 1.23 1.61 2.07 0.00 0.00
Price to Tangible Book Value (P/TBV)		 10.00 6.98 1.39 1.03 1.35 3.56 3.36 15.58 2.13 0.00 0.00
Price to Revenue (P/Rev)		 1.65 0.00 0.29 0.18 0.19 0.16 7.02 16.42 4.07 2.63 2.20
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6.21 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 16.10% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.94 0.74 1.07 0.89 0.88 1.02 1.19 1.32 1.19 1.64 1.66
Enterprise Value to Revenue (EV/Rev)		 2.28 0.00 0.34 0.49 0.29 0.24 8.13 25.64 12.40 11.62 10.76
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.92 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.15 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.15 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 6.42 38.77 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 2.07 0.94 0.00 2.00 0.41 0.33 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.43 0.47 0.32 1.73 0.63 0.82 0.23 0.92 4.26 -4.59 -4.08
Long-Term Debt to Equity		 0.26 0.22 0.32 0.39 0.35 0.31 0.00 0.68 2.96 -3.49 -3.02
Financial Leverage		 0.50 0.59 -0.28 0.41 0.40 0.41 0.21 0.93 4.03 -4.78 6.47
Leverage Ratio		 2.23 2.22 2.54 2.57 2.73 2.99 1.52 2.03 5.50 -4.30 8.38
Compound Leverage Factor		 3.11 2.54 2.64 3.13 3.31 3.20 1.62 1.96 5.61 -4.45 7.38
Debt to Total Capital		 29.83% 31.76% 24.44% 63.40% 38.54% 45.11% 18.58% 47.89% 81.00% 127.85% 132.43%
Short-Term Debt to Total Capital		 11.59% 16.93% 0.00% 49.16% 17.23% 28.03% 18.58% 12.50% 24.78% 30.74% 34.53%
Long-Term Debt to Total Capital		 18.24% 14.83% 24.44% 14.24% 21.31% 17.09% 0.00% 35.39% 56.22% 97.12% 97.90%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 70.16% 68.23% 75.56% 36.60% 61.46% 54.88% 81.42% 52.11% 19.00% -27.85% -32.43%
Debt to EBITDA		 -0.83 -0.75 -0.12 -0.47 -0.13 -0.09 -1.76 3.26 -1.82 -1.10 -0.92
Net Debt to EBITDA		 -0.69 -0.71 -0.08 -0.37 -0.11 -0.08 -1.50 3.21 -1.81 -1.08 -0.90
Long-Term Debt to EBITDA		 -0.51 -0.35 -0.12 -0.11 -0.07 -0.03 0.00 2.41 -1.26 -0.84 -0.68
Debt to NOPAT		 -1.26 -0.97 -0.13 -0.56 -0.16 -0.11 -2.35 3.34 -2.55 -1.55 -1.30
Net Debt to NOPAT		 -1.05 -0.92 -0.09 -0.44 -0.13 -0.10 -2.01 3.29 -2.53 -1.53 -1.27
Long-Term Debt to NOPAT		 -0.77 -0.45 -0.13 -0.13 -0.09 -0.04 0.00 2.47 -1.77 -1.18 -0.96
Altman Z-Score		 -0.16 -1.05 -3.34 -2.69 -3.24 -5.06 1.48 2.03 -2.25 -3.11 -2.31
Noncontrolling Interest Sharing Ratio		 -0.29% -0.51% -1.47% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.93 0.70 0.90 0.69 0.58 0.37 1.74 3.41 2.20 1.72 1.64
Quick Ratio		 0.30 0.22 0.10 0.27 0.15 0.04 0.10 0.04 0.03 0.06 0.08
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 23 30 -1.38 20 27 23 -105 -322 -374 -256 -74
Operating Cash Flow to CapEx		 100.96% 429.10% 1,009.14% 0.00% 0.00% -2,545.72% -2,258.47% -65,962.24% 0.00% -40,742.43% 0.00%
Free Cash Flow to Firm to Interest Expense		 21.81 41.31 -2.69 69.61 119.89 94.77 -255.04 -119.10 -103.77 -69.49 0.00
Operating Cash Flow to Interest Expense		 0.18 1.06 5.31 -6.80 -6.07 -3.18 -10.45 -3.62 -0.74 -1.30 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.82 4.78 6.42 -6.07 -3.30 -10.91 -3.63 -0.70 -1.30 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.21 0.00 0.61 0.54 0.48 0.47 0.21 0.09 0.17 0.24 0.16
Accounts Receivable Turnover		 2.00 0.00 30.54 4.25 5.82 6.94 41.37 38.12 28.18 77.18 196.25
Inventory Turnover		 0.00 0.00 4.23 1.52 1.17 1.49 3.83 3.35 3.23 4.40 3.71
Fixed Asset Turnover		 1.93 0.00 10.20 4.45 3.90 3.57 7.17 9.69 18.44 23.61 22.12
Accounts Payable Turnover		 0.00 0.00 17.45 4.51 4.92 4.26 6.50 3.24 5.73 3.98 3.99
Days Sales Outstanding (DSO)		 182.07 0.00 11.95 85.90 62.76 52.63 8.82 9.57 12.95 4.73 1.86
Days Inventory Outstanding (DIO)		 0.00 0.00 86.37 239.39 311.77 245.15 95.41 109.01 113.12 82.94 98.44
Days Payable Outstanding (DPO)		 0.00 0.00 20.92 80.92 74.21 85.67 56.15 112.60 63.74 91.77 91.38
Cash Conversion Cycle (CCC)		 182.07 0.00 77.41 244.37 300.33 212.10 48.08 5.98 62.33 -4.10 8.92
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 34 30 8.44 12 6.35 3.98 108 403 258 185 162
Invested Capital Turnover		 0.31 0.00 2.13 0.98 0.93 1.01 0.27 0.10 0.19 0.28 0.18
Increase / (Decrease) in Invested Capital		 -24 -34 -7.98 -21 -28 -26 100 391 251 181 54
Enterprise Value (EV)		 33 22 8.99 11 5.61 4.05 129 531 307 304 269
Market Capitalization		 24 12 7.54 4.09 3.65 2.76 111 340 101 69 55
Book Value per Share		 $1.25 $1.06 $0.31 $0.24 $3.61 $1.40 $2.42 $3.58 $0.81 ($0.74) ($0.77)
Tangible Book Value per Share		 $0.12 $0.08 $0.26 $0.19 $2.61 $0.59 $0.89 $0.37 $0.79 ($0.77) ($0.78)
Total Capital		 36 32 8.62 14 6.12 3.37 111 405 256 186 166
Total Debt		 11 10 2.11 8.71 2.36 1.52 21 194 208 238 220
Total Long-Term Debt		 6.62 4.79 2.11 1.96 1.31 0.58 0.00 143 144 181 162
Net Debt		 8.98 9.77 1.45 6.92 1.95 1.29 18 191 206 235 214
Capital Expenditures (CapEx)		 0.19 0.18 0.27 -3.84 0.00 0.03 0.19 0.01 -0.16 0.01 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.69 -2.38 -1.90 1.99 -3.86 -6.11 42 204 155 105 97
Debt-free Net Working Capital (DFNWC)		 2.53 -1.88 -1.24 3.78 -3.45 -5.88 45 206 157 108 103
Net Working Capital (NWC)		 -1.67 -7.35 -1.24 -2.98 -4.51 -6.83 24 156 93 51 46
Net Nonoperating Expense (NNE)		 2.01 3.49 1.64 0.69 0.55 1.32 2.37 2.41 56 35 5.05
Net Nonoperating Obligations (NNO)		 8.98 7.66 1.92 7.38 2.58 2.12 18 192 209 237 216
Total Depreciation and Amortization (D&A)		 1.24 1.06 1.29 0.26 0.24 0.59 -0.30 0.95 1.11 1.06 0.99
Debt-free, Cash-free Net Working Capital to Revenue		 4.83% 0.00% -7.17% 8.85% -20.29% -36.07% 264.36% 985.93% 627.70% 400.93% 388.64%
Debt-free Net Working Capital to Revenue		 17.74% 0.00% -4.67% 16.83% -18.16% -34.71% 283.18% 996.75% 634.24% 414.25% 411.76%
Net Working Capital to Revenue		 -11.72% 0.00% -4.67% -13.29% -23.71% -40.28% 153.14% 752.43% 377.50% 195.05% 182.56%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($2.40) ($4.00) ($250.20) ($1.55) ($1.24) ($2.87) ($0.88) $0.00 $0.00 ($1.67) ($0.39)
Adjusted Weighted Average Basic Shares Outstanding		 1.02M 1.04M 51.36K 1.05M 1.05M 1.34M 7.91M 55.34M 60.83M 65.51M 63.54M
Adjusted Diluted Earnings per Share		 ($2.40) $0.00 ($250.20) ($1.55) ($1.24) ($2.87) ($0.88) $0.00 $0.00 ($1.67) ($0.39)
Adjusted Weighted Average Diluted Shares Outstanding		 1.02M 1.04M 51.36K 1.05M 1.05M 1.34M 7.91M 88.48M 60.83M 65.51M 63.54M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 ($250.20) $0.00 $0.00 $0.00 ($0.88) $0.00 $0.00 $0.00 ($0.39)
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 1.04M 1.04M 0.00 1.04M 1.32M 37.25M 58.89M 59.92M 69.76M 70.26M 82.10M
Normalized Net Operating Profit after Tax (NOPAT)		 -1.39 -3.38 -9.36 -0.93 -0.75 -2.51 -4.55 -6.19 -6.61 -75 -19
Normalized NOPAT Margin		 -18.67% -64.67% -172.40% -21.45% -18.76% -79.45% -106.16% -66.98% -82.13% -1,640.31% -619.06%
Pre Tax Income Margin		 -49.08% -110.76% -255.47% -37.31% -32.49% -121.24% -161.48% 722.40% -2,222.11% -2,399.42% -779.39%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -2.53 -6.85 -26.06 -4.60 -4.70 -14.63 -15.86 25.62 -48.64 -28.69 0.00
NOPAT to Interest Expense		 -1.76 -4.79 -18.26 -3.22 -3.29 -10.24 -11.10 25.62 -34.05 -20.29 0.00
EBIT Less CapEx to Interest Expense		 -2.71 -7.10 -26.59 8.62 -4.70 -14.76 -16.32 25.61 -48.59 -28.69 0.00
NOPAT Less CapEx to Interest Expense		 -1.94 -5.04 -18.79 10.00 -3.29 -10.37 -11.57 25.61 -34.01 -20.30 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -2.96%

Financials Breakdown Chart

Key Financial Trends

Upexi’s financial results show a sharp deterioration in operating momentum during fiscal 2026. Revenue increased to $9.2 million in Q1 2026 from $4.4 million in Q1 2025, but then declined each quarter to $8.1 million in Q2, $4.6 million in Q3 and $3.1 million in Q4. Q4 revenue was down approximately 26% from the same quarter a year earlier. Gross margins remained unusually high in the latest quarter at roughly 96%, but this was not enough to offset operating expenses.

The company has reported operating and net losses in most periods. Although Upexi recorded a $66.7 million net profit in Q1 2026, that result was heavily influenced by unusual income and nonrecurring items. It then posted net losses of $178.9 million in Q2, $109.3 million in Q3 and $24.5 million in Q4. Large special charges and other operating expenses were significant contributors to the losses, including a $164.5 million special charge in Q2 and a $105.5 million other operating expense in Q3. Q4 included an $85.5 million negative other operating expense adjustment.

Cash generation remains a major concern. Operating cash flow was negative in every quarter of fiscal 2026, ranging from negative $2.7 million to negative $9.8 million. In Q4, a $7.7 million common-stock issuance and other financing activity helped produce a $2.3 million increase in cash despite negative operating and investing cash flow. At the latest reported balance-sheet date, cash was only $3.5 million, compared with total debt of approximately $238.3 million. Shareholders’ equity had also turned negative at $51.9 million.

  • High reported gross margins: Q4 2026 gross profit was $3.0 million on $3.1 million of revenue, implying a gross margin near 96%, although investors should assess whether this margin is sustainable.
  • Financing provided short-term liquidity: Upexi raised $7.7 million through common-stock issuance in Q4 2026, allowing cash and equivalents to increase by $2.3 million during the quarter.
  • Debt repayment occurred in earlier periods: The company repaid $10.96 million of debt in Q3 2026 and $7.6 million in Q1 2026, showing some effort to manage borrowings.
  • Large noncash adjustments complicate results: Q4 operating cash flow included $239.8 million of noncash adjustments against a reported cash-flow net loss of $246.1 million, making reported earnings and cash-flow trends difficult to interpret.
  • Balance-sheet assets are concentrated in unusual categories: At Q3 2026, more than $116 million of current assets were classified as other current assets, while more than $70 million of noncurrent assets were classified as other noncurrent operating assets. The composition and recoverability of these balances warrant close review.
  • Revenue momentum weakened materially: Quarterly revenue fell from $9.2 million in Q1 2026 to $3.1 million in Q4 2026, reversing the growth seen at the beginning of the fiscal year.
  • Operating cash flow remained negative: Upexi generated negative operating cash flow in each fiscal 2026 quarter, indicating that reported revenue and gross profit have not translated into internally generated cash.
  • Heavy debt burden: Q3 2026 short- and long-term debt totaled approximately $238.3 million, substantially exceeding the company’s $3.5 million cash balance.
  • Negative shareholders’ equity: Total equity declined from positive $48.7 million at Q2 2026 to negative $51.9 million at Q3 2026, reflecting the impact of large losses and adjustments.
  • Frequent restatements and unusual charges raise uncertainty: Several earlier periods are identified as restated, while quarterly results contain unusually large special charges, impairments and other operating adjustments. This reduces the reliability of simple year-over-year comparisons.
10/07/26 05:37 AM ETAI Generated. May Contain Errors.

Upexi Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Upexi's fiscal year ends in June. Their fiscal year 2026 ended on June 30, 2026.

Upexi's net income appears to be on a downward trend, with a most recent value of -$246.06 million in 2026, falling from -$5.38 million in 2020. The previous period was -$13.68 million in 2025. See where experts think Upexi is headed by visiting Upexi's forecast page.

Upexi's total operating income in 2026 was -$240.85 million, based on the following breakdown:
  • Total Gross Profit: $22.37 million
  • Total Operating Expenses: $263.21 million

Over the last 6 years, Upexi's total revenue changed from $7.41 million in 2020 to $25.00 million in 2026, a change of 237.2%.

In the past 10 quarters, Upexi's cash and equivalents has ranged from $230.39 thousand in Q3 2025 to $3.48 million in Q3 2026, and is currently $3.48 million as of their latest financial filing in Q3 2026.

Upexi had total debt of $219.74 million at the end of 2026, a 968.8% increase from 2025, and a 10,624.4% increase since 2020.

Over the last 6 years, Upexi's book value per share changed from 0.04 in 2020 to -0.77 in 2026.


Related Companies

Financial statements for NASDAQ:UPXI last updated on 9/17/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel